You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
58 search results for: symposium
expert video
Epidemiology and Pathophysiology of AD in Children
In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses the epidemiology of AD in children and the role of type 2 cytokines in driving the pathophysiology of the disease
expert video
expert video
IL-4 Contributes to Systemic Type 2 Inflammation in AD
In this highlight video from the ADVENT AD symposium held at EADV’s 2024 Annual Meeting in Amsterdam, Dr. Stephan Weidinger discusses how IL-4 contributes to systemic type 2 inflammation in AD via several mechanisms, including T cell differentiation, B cell activation and IgE generation, and T regulatory cell inhibition.
expert video
Key Treatment Considerations for Management of Atopic Dermatitis in Children
In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the key considerations for management of AD that is uncontrolled with topical therapies in children and the criteria to determine whether a patient is indicated for systemic therapy
expert video
The Journey of Diagnosis: Disease Burden and Diagnostic Considerations for Atopic Dermatitis and Prurigo Nodularis
In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on diagnostic considerations and challenges associated with atopic dermatitis and prurigo nodularis.
expert video
Identification and Management of AD Uncontrolled With Topical Therapies in Children
In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang discusses how to identify pediatric patients with AD uncontrolled with topical therapies, considerations for the next step in care for these patients, and the potential benefits of early intervention with systemic treatment
expert video
How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?
In this video from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson discusses how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation. The associated inflammatory process can contribute to the pathophysiology of several dermatological diseases, including AD, PN, CSU, and BP.
expert video
Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic dermatitis?
In this video from the 2024 Society for Pediatric Dermatology Symposium held in Toronto, Canada, Dr. Amy Paller, MD and Dr. Peter Leo, MD discusses the role of atopic dermatitis as a risk factor for developing food allergies. Moreover, explores the potential opportunities for early intervention to alter disease trajectories and the possibilities for disease modification in atopic dermatitis.
expert video
Type 2 Inflammation
In this video from the 2024 Society for Pediatric Dermatology Symposium held in Toronto, Canada, Dr. Peter Leo, MD and Dr. Amy Paller, MD discusses the multifaceted nature of atopic diseases, including environmental triggers, key Type 2 inflammatory mechanisms, and associated health risks, to understand the importance of early intervention in managing and potentially modifying disease progression.
expert video
New Data on the Systemic (Multi-Organ) Burden of AD in Children and the Need for Early Intervention
This video from the March 2024 ADVENT AD symposium features Dr. Lawrence Eichenfield presenting the systemic burdens of AD in children and the need for early intervention. Dr. Eichenfield also reviews the multidimensional, atopic, and non-atopic burdens associated with AD in pediatric patients. He goes on to discuss evidence on benefits of early intervention and how it may prevent the progression of local and systemic inflammatory processes over time, followed by a brief panel discussion.
expert video
Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis
In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.
expert video
Practical Considerations in Older Patients with AD
This video from the March 2024 ADVENT AD symposium features Dr. Katrina Abuabara presenting on practical considerations in older patients with AD. Dr. Abuabara elaborates on several unique challenges faced by older adult patients with AD, including differential diagnoses and age-dependent clinical factors and decisions relevant to their disease management. She goes on to discuss the concept of “inflamm-aging” as it relates to systemic inflammatory markers and associated comorbidities in older adult patients, followed by a brief panel discussion.
